• #1056253
  • Fidia Pharma USA Inc #89122049663

Hymovis® Hyaluronate, Modified, Non-crosslinked 8 mg / mL Injection Prefilled Syringe 3 mL

HYMOVIS, SYR 24MG/3ML (2/EA)

Features

  • HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen)
  • HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel contained in a single-use syringe
  • HYMOVIS® has a hyaluronan (HYADD®4) concentration of 8 mg/mL, dissolved in physiologic saline
  • More …
  Log In to Order
or

Product Specifications


Features
  • HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen)
  • HYMOVIS® is a sterile, non-pyrogenic, viscoelastic hydrogel contained in a single-use syringe
  • HYMOVIS® has a hyaluronan (HYADD®4) concentration of 8 mg/mL, dissolved in physiologic saline
  • HYMOVIS® is supplied in a set of 2 single-use 5 mL syringes, each containing a 3 mL dose of treatment to be injected one week apart

Professionals Also Viewed